IL138292A - Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor - Google Patents
Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitorInfo
- Publication number
- IL138292A IL138292A IL13829299A IL13829299A IL138292A IL 138292 A IL138292 A IL 138292A IL 13829299 A IL13829299 A IL 13829299A IL 13829299 A IL13829299 A IL 13829299A IL 138292 A IL138292 A IL 138292A
- Authority
- IL
- Israel
- Prior art keywords
- medicament
- treating
- preventing
- aromatase inhibitor
- mammary carcinoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98104949A EP0943333A1 (de) | 1998-03-18 | 1998-03-18 | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
PCT/EP1999/001374 WO1999047143A1 (de) | 1998-03-18 | 1999-03-03 | Medikament zur prophylaxe und/oder behandlung des mammakarzinoms enthaltend einen steroidalen aromataseinhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
IL138292A0 IL138292A0 (en) | 2001-10-31 |
IL138292A true IL138292A (en) | 2005-08-31 |
Family
ID=8231611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13829299A IL138292A (en) | 1998-03-18 | 1999-03-03 | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0943333A1 (ko) |
JP (1) | JP4920822B2 (ko) |
KR (1) | KR100778803B1 (ko) |
CN (1) | CN1168448C (ko) |
AT (1) | ATE230995T1 (ko) |
AU (1) | AU751040B2 (ko) |
BR (1) | BR9908885A (ko) |
CA (1) | CA2324077C (ko) |
CZ (1) | CZ292643B6 (ko) |
DE (1) | DE59904042D1 (ko) |
DK (1) | DK1063998T3 (ko) |
ES (1) | ES2190201T3 (ko) |
HU (1) | HU226105B1 (ko) |
ID (1) | ID26965A (ko) |
IL (1) | IL138292A (ko) |
PL (1) | PL343100A1 (ko) |
RU (1) | RU2225206C2 (ko) |
SK (1) | SK285349B6 (ko) |
WO (1) | WO1999047143A1 (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042411A1 (de) * | 2000-08-30 | 2002-03-28 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Exemestan |
DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
JP4524296B2 (ja) * | 2007-03-30 | 2010-08-11 | 生化学工業株式会社 | 発毛促進剤 |
DE102007032468A1 (de) | 2007-07-10 | 2009-01-15 | Brätter, Christian, Dr. | Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten |
JP6091431B2 (ja) * | 2011-01-31 | 2017-03-15 | ルコラス−エム.ディー.リミテッド | 医薬的使用 |
EP2670382B1 (de) * | 2011-01-31 | 2018-07-18 | LUCOLAS-M.D. Ltd. | Kosmetische verwendung |
US11850451B2 (en) | 2011-01-31 | 2023-12-26 | Lucolas-M.D. Ltd. | Cosmetic compositions and methods for improving skin conditions |
EP3666276A1 (en) * | 2018-12-14 | 2020-06-17 | dcic Biopharmaceutical Limited | Medication against estrogen-receptor beta (erbeta) positive breast tumor |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
DE3322285A1 (de) * | 1983-06-18 | 1984-12-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
JPS6345294A (ja) * | 1986-04-07 | 1988-02-26 | Shionogi & Co Ltd | アロマタ−ゼ阻害ステロイド誘導体 |
EP0310542B1 (de) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren |
FR2656310B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
DE4039559A1 (de) * | 1990-12-07 | 1992-06-11 | Schering Ag | Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln |
GB9212833D0 (en) * | 1992-06-17 | 1992-07-29 | Glaxo Group Ltd | Chemical compounds |
PT689536E (pt) * | 1993-03-16 | 2001-11-30 | Pfizer | Derivados de naftaleno |
JPH07215992A (ja) * | 1993-12-07 | 1995-08-15 | Teikoku Hormone Mfg Co Ltd | 6−又は7−置換アンドロスタ−1,4−ジエン誘導体 |
ATE197889T1 (de) * | 1994-09-14 | 2000-12-15 | Univ Sheffield | Kontrolle des haarwuchses |
US5780050A (en) * | 1995-07-20 | 1998-07-14 | Theratech, Inc. | Drug delivery compositions for improved stability of steroids |
ATE200978T1 (de) * | 1996-03-29 | 2001-05-15 | S W Patentverwertungs Ges M B | KOSMETIKUM BZW. KOSMETIKZUSAMMENSETZUNG ZUR GLÄTTUNG UND STRAFFUNG DER HAUT BEI GESTÖRTEM UNTERHAUT-BINDE-FETTGEWEBE, INSBESONDERE BEI DER ßCELLULITEß |
ATE279916T1 (de) * | 1996-07-22 | 2004-11-15 | Renovo Ltd | Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden |
-
1998
- 1998-03-18 EP EP98104949A patent/EP0943333A1/de not_active Withdrawn
-
1999
- 1999-03-03 RU RU2000126276/15A patent/RU2225206C2/ru active IP Right Revival
- 1999-03-03 SK SK1342-2000A patent/SK285349B6/sk unknown
- 1999-03-03 ID IDW20002095A patent/ID26965A/id unknown
- 1999-03-03 WO PCT/EP1999/001374 patent/WO1999047143A1/de active IP Right Grant
- 1999-03-03 AT AT99913218T patent/ATE230995T1/de active
- 1999-03-03 KR KR1020007010177A patent/KR100778803B1/ko not_active IP Right Cessation
- 1999-03-03 HU HU0101005A patent/HU226105B1/hu not_active IP Right Cessation
- 1999-03-03 CA CA002324077A patent/CA2324077C/en not_active Expired - Fee Related
- 1999-03-03 JP JP2000536383A patent/JP4920822B2/ja not_active Expired - Lifetime
- 1999-03-03 CZ CZ20003256A patent/CZ292643B6/cs not_active IP Right Cessation
- 1999-03-03 DE DE59904042T patent/DE59904042D1/de not_active Expired - Lifetime
- 1999-03-03 CN CNB998064009A patent/CN1168448C/zh not_active Expired - Lifetime
- 1999-03-03 BR BR9908885-1A patent/BR9908885A/pt not_active Application Discontinuation
- 1999-03-03 ES ES99913218T patent/ES2190201T3/es not_active Expired - Lifetime
- 1999-03-03 AU AU31434/99A patent/AU751040B2/en not_active Expired
- 1999-03-03 PL PL99343100A patent/PL343100A1/xx unknown
- 1999-03-03 DK DK99913218T patent/DK1063998T3/da active
- 1999-03-03 EP EP99913218A patent/EP1063998B1/de not_active Expired - Lifetime
- 1999-03-03 IL IL13829299A patent/IL138292A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ID26965A (id) | 2001-02-22 |
CZ20003256A3 (cs) | 2001-04-11 |
PL343100A1 (en) | 2001-07-30 |
ES2190201T3 (es) | 2003-07-16 |
KR100778803B1 (ko) | 2007-11-27 |
IL138292A0 (en) | 2001-10-31 |
CN1168448C (zh) | 2004-09-29 |
SK13422000A3 (sk) | 2001-05-10 |
CA2324077A1 (en) | 1999-09-23 |
EP1063998A1 (de) | 2001-01-03 |
CZ292643B6 (cs) | 2003-11-12 |
HUP0101005A2 (hu) | 2001-08-28 |
DK1063998T3 (da) | 2003-05-12 |
BR9908885A (pt) | 2000-11-21 |
JP4920822B2 (ja) | 2012-04-18 |
AU751040B2 (en) | 2002-08-08 |
ATE230995T1 (de) | 2003-02-15 |
DE59904042D1 (de) | 2003-02-20 |
CA2324077C (en) | 2008-07-29 |
RU2225206C2 (ru) | 2004-03-10 |
HU226105B1 (en) | 2008-04-28 |
JP2002506823A (ja) | 2002-03-05 |
AU3143499A (en) | 1999-10-11 |
CN1301165A (zh) | 2001-06-27 |
EP1063998B1 (de) | 2003-01-15 |
EP0943333A1 (de) | 1999-09-22 |
WO1999047143A1 (de) | 1999-09-23 |
KR20010034603A (ko) | 2001-04-25 |
SK285349B6 (sk) | 2006-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
SI1556058T1 (sl) | Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka | |
IL150767A (en) | Benzophyrene compounds and their use in the manufacture of drugs for the treatment of estrogen-sensitive diseases such as endometrial cancer | |
FR2791573B1 (fr) | Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate | |
CA2301032A1 (en) | A method of preventing or treating estrogen-dependent diseases and disorders | |
MXPA03005742A (es) | Combinacion de un estrogeno y un androgeno para tratar deficiencias hormonales en mujeres que sufren terapia de reemplazo de estrogenos. | |
MY164077A (en) | Compositions and uses of et743 for treating cancer | |
IL138292A (en) | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor | |
NZ504928A (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
IL124881A0 (en) | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
GB0008172D0 (en) | Therapy | |
PL357179A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
BR0111740A (pt) | Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação | |
SI1140147T1 (sl) | Terapija s hcg za zdravljenje metastatskega raka na dojki | |
NZ337048A (en) | Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer | |
ZA200209835B (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites. | |
WO2001036048A8 (en) | Phorboxazole derivatives for treating cancer | |
CY1109852T1 (el) | Συμπληρωμα ασβεστιου για τον περιορισμο του κινδυνου καρκινου του προστατη | |
ZA97215B (en) | Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
AU6739690A (en) | Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans | |
IT1314187B1 (it) | Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso | |
EP1385497A4 (en) | METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN | |
AU3145400A (en) | Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin | |
NZ336321A (en) | Use of benzothiophene (raloxifene) for treating breast cancer | |
NZ516564A (en) | Cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees | ||
NE | Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967) | ||
KB | Patent renewed | ||
EXP | Patent expired |